Immunological mechanisms of specific immunotherapy with pollen vaccines: implications for diagnostics and the development of improved vaccination strategies

References

• Beasley R. The burden of asthma with specific reference to the United States. J. Allergy Gun. Immune]. 109(5 Suppl), S482-S489 (2002).
   Google Scholar
• Janson C, Anto J, Burney P et al. The European Community Respiratory Health Survey: what are the main results so far? Fnr Respir. 18(3), 598–611 (2001).
   Google Scholar
• •Summarizes the results from an ongoing respiratory health survey including 140,000 individuals in 22 countries.
   Google Scholar
• Vartiainen E, Petays T, Haahtela T, Jousilahti P, Pekkanen J. Allergic diseases, skin prick test responses and IgE levels in North Karelia, Finland and the Republic of Karelia, Russia. J. Allergy Clin. Immune]. 109(4), 643–648 (2002).
   Google Scholar
• D'Amato G, Spieksma FTM, Liccardi G et al Pollen-related allergy in Europe. Allergy53(6), 567–578 (1998).
   PubMed Web of Science ®Google Scholar
• Vieths S, Scheurer S, Ballmer-Weber B. Current understanding of cross-reactivity of food allergens and pollen. Ann. NY Acad. Sc]. 964,47–68 (2002).
   PubMed Web of Science ®Google Scholar
• Fogle-Hansson M, Bende M. The significance of hypersensitivity to nuts in patients with birch pollen allergy. Allergy 48(4), 282–284 (1993).
   PubMedGoogle Scholar
• Jarolim E, Rumpold H, Endler AT, Ebner H, Breitenbach M, Schemer 0, Kraft D. IgE and IgG antibodies of patients with allergy to birch pollen as tools to defme the allergen profile of Betula verrucosa. Allergy 44(6), 385–395 (1989).
   Google Scholar
• Kazemi-Shirazi L, Niederberger V, Linhart B, Lidholm J, Kraft D, Valenta R Recombinant marker allergens: diagnostic gatekeepers for the treatment of allergy Lit. Arrh. Allergy Immunol 127(4), 259–268 (2002).
   PubMedGoogle Scholar
• •Discusses cross-reactivity between pollen and food allergens and how component-resolved diagnostics may be used to select patients for pollen SIT.
   Google Scholar
• Luttkopf D, Muller U, Skov PS et al Comparison of four variants of a major allergen in hazelnut (Corylus avellan Cor a 1.04 with the major hazel pollen allergen Cora 1.01. Md. Immunol 38(7), 515–525 (2002).
   Google Scholar
• Wensing M, Akkerclaas JH, van Leeuwen WA etal. IgE to Bet v 1 and profilin: cross-reactivity patterns and clinical relevance. J. Allergy Clin. Immunol 110(3), 435–442 (2002).
   Google Scholar
• Valenta R, Duchene M, Ebner C et al Profflins constitute a novel family of functional plant pan-allergens. J. Exp. Med. 175(2), 377–385 (1992).
   Google Scholar
• Scheurer S, Wangorsch A, Nerkamp J et al Cross-reactivity within the profilin panallergen family investigated by comparison of recombinant profilins from pear (Pyr c 4), cherry (Pru av 4) and celery (Api g 4) with birch pollen profilin Bet v 2. Chromatogr. Biomed. Sc]. Appl. 756(1–4 315–325 (2001).
   Google Scholar
• Swoboda I, Jilek A, Ferreira F et al. Isoforms of Bet v 1, the major birch pollen allergen, analyzed by liquid chromatography, mass spectrometry and cDNA doning. j Biol. Chem 270 (6), 2607–2613 (1995).
   Google Scholar
• Pauli G, Oster JP, Deviller P et al Skin testing with recombinant allergens rBet v 1 and birch profilin, rBet v 2: diagnostic value for birch pollen and associated allergies. J. Allergy Clin. Immunol 97(5), 1100–1109 (1996).
   Google Scholar
• Valenta R, Duchene M, Vrtala S et al Recombinant allergens for immunoblot diagnosis of tree-pollen allergy. J. Allergy Clin. Immunol 88(6), 889–894 (1991).
   Google Scholar
• Twardosz A, Hayek B, Seiberler S et al. Molecular characterization, expression in Escherichia coil and epitope analysis of a two EF-hand calcium-binding birch pollen allergen, Bet v 4. Biochem. Biophys. Res. Commun. 239(1), 197–204 (1997).
   Google Scholar
• Moverare R, Westritschnig K, Svensson M et al Different IgE reactivity profiles in birch pollen-sensitive patients from six European populations revealed by recombinant allergens. An inprint of local sensitization. Lit. Arch. Allergy Immunol 128(4), 325–335 (2002).
   Google Scholar
• Laffer S, Spitzauer S, Susani M et al. Comparison of recombinant timothy grass pollen allergens with natural extract for diagnosis of grass pollen allergy in different populations. J. Allergy Clin. Immunol 98(3), 652–658 (1996).
   Google Scholar
• Hirschwehr R, Valenta R, Ebner C et al Identification of common allergenic structures in hazel pollen and hazelnuts: a possible explanation for sensitivity to hazelnuts in patients allergic to tree pollen. Allergy Clin. Immunol 90(6 Pt 1), 927–936 (1992).
   Google Scholar
• Kazemi-Shirazi L, Pauli G, Purohit A et al Quantitative IgE inhibition experiments with purified recombinant allergens indicate pollen-derived allergens as the sensitizing agents responsible for many forms of plant food allergy. J. Allergy Clin. Immunol 105(1 Pt 1), 116–125 (2000).
   Google Scholar
• •Demonstrates that pollen-related food allergy in most cases is due to IgE sensitization to pollen allergens and not the vice versa.
   Google Scholar
• van Pee R, Fernandez Rivas M, Cuevas M, van Wijngaarden M, Aalberse RC. Pollen-related allergy to peach and apple: an important role for profilin. J. Allergy Clin. Immunol 95(3), 726–734 (1995).
   Google Scholar
• Diez-Gomez ML, Quirce S, Cuevas M et al Fruit-pollen-latex cross-reactivity: implication of profilin (Bet v 2). Allergy 54(9), 951–961 (1999).
   Google Scholar
• Punnonen J, Aversa G, Cocks BG et al. Interleukin-13 induces interleukin-4-independent IgG4 and IgE synthesis and CD23 expression by human B-cells. Proc. Natl Acad. Li. USA 90 (8), 3730–3734 (1993).
   Google Scholar
• Pene J, Rousset F, Briere F, Chretien I et al. IgE production by normal human lymphocytes is induced by interleukin-4 and suppressed by interferons gamma and alpha and prostaglandin E2. Proc. Nail Acad. Li. USA 85(18), 6880–6884 (1988).
   Google Scholar
• Gabrielsson S, Soderlund A, Paulie S, Pak S, van der Pouw Kraan IC, Troye-Blomberg M. Increased frequencies of allergen-induced interleuldn-13-producing cells in atopic individuals during the pollen season. Land immund. 48,429-435 (1998).
   Google Scholar
• Kimura M, Tsuruta S, Yoshida T Unique profile of IL-4 and IFN-gamma production by peripheral blood mononuclear cells in infants with atopic dermatitis. J. Allergy Immunol 102(2), 238–244 (1998).
   Google Scholar
• Moverare R, Elfman L, Stalenheim G, Bjomsson E. Study of the Th1/Th2 balance, including the IL-10 production, in cultures of peripheral blood mononuclear cells from birch-pollen-allergic patients. Allergy 55 (2), 171–175 (2000).
   Google Scholar
• Moverare R, Elfman L, Bjomsson E, Stalenheim G. Changes in cytokine production in vitro during the early phase of birch-pollen immunotherapy. Land Immunol 52,200–206 (2000).
   Google Scholar
• Ebner C, Schenk S, Szepfalusi Z et al. Multiple T-cell specificities for Bet vi, the major birch pollen allergen, within single individuals. Studies using specific T-cell clones and overlapping peptides. FIR: J. Immunol 23(7), 1523–1527 (1993).
   Google Scholar
• Gabrielsson S, Paulie S, Pak S et al Specific induction of interleukin-4-producing cells in response to in vitro allergen stimulation in atopic individuals. Clin. Exp. Allergy 27(7), 808–815 (1997).
   Google Scholar
• Ebner C, Siemann U, Najafian N, Scheiner 0, Kraft D. Characterization of allergen (Bet v 1)-specific T-cell lines and clones from non-allergic individuals. Lit. Arch. Allergy Immunol 107(1–3), 183–185 (1995).
   Google Scholar
• Church MK, Bradding P, Walls AF, Okayama K. Human mast cells and basophils. In: Allergy and allergic diseases (Volume I). Kay AB (Ed.). Blackwell Science, Oxford, UK, 149–170 (1997).
   Google Scholar
• Borish L, Joseph BZ. Inflammation and the allergic response. Med Clin. North Am. 76(4), 765–787 (1992).
   PubMedGoogle Scholar
• Montefort S, Gratziou C, Goulding D et al. Bronchial biopsy evidence for leukocyte infiltration and upregulation of leukocyte-endothelial cell adhesion molecules 6 h after local allergen challenge of sensitized asthmatic airways. J. Clin. Invest. 93 (4), 1411–1421 (1994).
   Google Scholar
• Gleich GJ. Mechanisms of eosinophil- associated inflammation. J. Allergy Clin. Immunol 105(4), 651–663 (2000).
   Google Scholar
• Amin K, Ludviksdottir D, Janson C etal. Inflammation and structural changes in the airways of patients with atopic and nonatopic asthma. ATIZ Repir Grit. Care Med 162(6), 2295–2301 (2000).
   Google Scholar
• Varney VA, Jacobson MR, Sudderick PM et al. Immunohistology of the nasal mucosa following allergen-induced rhinitis. Identification of activated T-lymphocytes, eosinophils and neutrophils. Am. Rev Respir. Dis. 146(1), 170–176 (1992).
   Google Scholar
• Hamelmann E, Gelfand RV. Role of IL-5 in the development of allergen-induced airway hyperresponsiveness. Int. Arch. Allergy Immunol 120(1), 8–16 (1999).
   Google Scholar
• Yamaguchi Y, Hayashi Y, Sugama Y et al Highly purified murine interleukin-5 5) stimulates eosinophil function and prolongs in vitrosurvival. IL-5 as an eosinophil chemotactic factor. J. Exp. Med. 167(5), 1737–1742 (1988).
   Google Scholar
• Desreumaux P, Capron M. Fnsinophils in allergic reactions. Curr. Opin. Immunol. 8(6), 790–795 (1996).
   Google Scholar
• Noon L, Cantab BC, Eng FRCS. Prophylactic inoculation against hay fever. Lancet 1, 1572–1573 (1911).
   Google Scholar
• •First publication concerning pollen SIT.
   Google Scholar
• Bousquet J, Lockey RF, Mailing HJ. Allergen immunotherapy — therapeutic vaccines for allergic diseases. Allergy 53\(Suppl. 44), 4–42 (1998).
   Google Scholar
• •Comprehensive review and WHO position paper for SIT with allergen vaccines.
   Google Scholar
• Mailing HJ, Abreu-Nogueira J, Alvarez- Cuesta E etal. Local immunotherapy. Allergy53(10), 933–944 (1998).
   PubMedGoogle Scholar
• •Comprehensive review of local SIT including sublingual and nasal administration (position paper).
   Google Scholar
• Kagi MK, VVuthrich B. Different methods of local allergen-specific immunotherapy. Allergy 57(5), 379–388 (2002).
   PubMedGoogle Scholar
• •Updated review of sublingual SIT and nasal SIT.
   Google Scholar
• Gjesing B, Jager L, Marsh DG, Lowenstein H. The international collaborative study establishing the first international standard for timothy (Phleum pratense) grass pollen allergenic extract. J. Allergy Clin. Immunol 75(2), 258–267 (1985).
   Google Scholar
• Arntzen FC, Wilhelmsen TW, Lowenstein H et al The international collaborative study on the first international standard of birch (Betula verrucos4 -pollen extract. J. Allergy Clin. Immunol 83(1), 66–82 (1989).
   Google Scholar
• Dreborg S. Skin testing in allergen standardization and research. Immunol. Allergy Clin. North Am. 21 (2), 329–354 (2001).
   Google Scholar
• Nordic Council on Medicines. Registration of allergen preparartions. Nordic guidelines. MLN Publication No 23, Uppsala, Sweden. (1989).
   Google Scholar
• US Department of Health and Human Services, FDA. Guidance for reviewers. Potency limits for standardized dust mite and grass allergen vaccines: A revised protocol (2000).
   Google Scholar
• Platts-Mills TA, Mueller GA, Wheatley LM. Future directions for allergen immunotherapy. J. Allergy Clin. Immunol. 102(3), 335–343 (1998).
   Google Scholar
• Pastorello EA, Pravettoni V, Incorvaia C etal. Clinical and immunological effects of immunotherapy with alum-absorbed grass allergoid in grass-pollen-induced hay fever. Allergy 47(4 Pt 1), 281–290 (1992).
   Google Scholar
• Bousquet J, Hejjaoui A, Skassa-Brociek W etal. Double-blind, placebo-controlled immunotherapy with mixed grass-pollen allergoids. I. Rush immunotherapy with allergoids and standardized orchard grass-pollen extract. J. Allergy Clin. Immunol. 80(4), 591–598 (1987).
   Google Scholar
• Gupta RK. Aluminum compounds as vaccine adjuvants. Adv Drug Deity Rev 32(3), 155–172 (1998).
   PubMed Web of Science ®Google Scholar
• Arvidsson MB, Lowhagen 0, Pak S. Effect of 2-year placebo-controlled immunotherapy on airway symptoms and medication in patients with birch pollen allergy. J. Allergy Clin. Immunol 109(5), 777–783 (2002).
   Google Scholar
• Reid MJ, Moss RB, Hsu YP, Kwasnicki JM, Commerford TM, Nelson BL. Seasonal asthma in northern California: allergic causes and efficacy of immunotherapy. Allergy Clin. Immunol. 78(4 Pt 1), 590–600 (1986).
   Google Scholar
• Dolz I, Martinez-Cocera C, Bartolome JM, Cimarra M. A double-blind, placebo-controlled study of immunotherapy with grass-pollen extract Alutard SQ during a 3-year period with initial rush immunotherapy. Allergy51(7), 489–500 (1996).
   Google Scholar
• Balda BR, Wolf H, Baumgarten C et al. Tree-pollen allergy is efficiently treated by short-term immunotherapy (STI) with seven preseasonal injections of molecular standardized allergens. Allergy 53(8), 740–748 (1998).
   PubMedGoogle Scholar
• Jacobsen L, Nuchel Petersen B, Wihl JA, Lowenstein H, Ipsen H. Immunotherapy with partially purified and standardized tree pollen extracts. IV. Results from long-term (6-year) follow-up. Allergy52(9), 914–920 (1997).
   Google Scholar
• Durham SR, Walker SM, Varga EM et al Long-term clinical efficacy of grass-pollen immunotherapy. N. Engl. Med. 341(7), 468–475 (1999).
   Google Scholar
• •Provides evidence for persistent clinical efficacy after discontinued pollen SIT.
   Google Scholar
• Ortolani C, Pastorello E, Moss RB et al. Grass pollen immunotherapy: a single year double-blind, placebo-controlled study in patients with grass pollen-induced asthma and rhinitis. J. Allergy Clin. Immunol. 73(2), 283–290 (1984).
   Google Scholar
• Adkinson NF Jr, Eggleston PA, Eney D et al A controlled trial of immunotherapy for asthma in allergic children. N Engl. J. Med. 336(5), 324–331 (1997).
   Google Scholar
• Moller C, Dreborg S, Ferdousi HA et al. Pollen immunotherapy reduces the development of asthma in children with seasonal rhinoconjunctivitis (the PAT-study) . J. Allergy Clin. Immunol. 109(2), 251–256 (2002).
   Google Scholar
• Pajno GB, Barberio G, De Luca F, Morabito L, Parmiani S. Prevention of new sensitizations in asthmatic children monosensitized to house dust mite by specific immunotherapy. A six-year follow-up study. Cita Exp. Allergy31 (9), 1392–1397 (2001).
   Google Scholar
• Des Roches A, Paradis L, Menardo JL, Bouges S, Daures, JP, Bousquet J. Immunotherapy with a standardized Dermatophagoides pteronyssinus extract. VI. Specific immunotherapy prevents the onset of new sensitizations in children. J. Allergy Clin. Immunol 99(4), 450–453 (1997).
   Google Scholar
• Durham SR, Ying S, Varney VA etal. Grass pollen immunotherapy inhibits allergen-induced infiltration of CD4+ T-lymphocytes and eosinophils in the nasal mucosa and increases the number of cells expressing messenger RNA for interferon-gamma. J. Allergy Clin. Immunol 97(6), 1356–1365 (1996).
   Google Scholar
• Furin MJ, Norman PS, Creticos PS, Proud D, Kagey Sobotka A, Lichtenstein LM, Naderio RM. Immunotherapy decreases antigen-induced eosinophil cell migration into the nasal cavity. J. Allergy Clin. Immunol. 88(1), 27–32 (1991).
   Google Scholar
• Pak S, Bjornson A, Hakanson L, Sorenson S, Venge P. The effect of immunotherapy on eosinophil accumulation and production of eosinophil chemotactic activity in the lung of subjects with asthma during natural pollen exposure. J. Allergy Clin. Immunol 88(6), 878–888 (1991).
   Google Scholar
• Hakansson L, Heinrich C, Rak S, Venge P. Priming of eosinophil adhesion in patients with birch pollen allergy during pollen season: effect of immunotherapy. J. Allergy Clin. Immunol 99(4), 551–562 (1997).
   Google Scholar
• Rak S, Lowhagen 0, Venge P The effect of immunotherapy on bronchial hyperresponsiveness and eosinophil cationic protein in pollen-allergic patients..! Allergy Clin. Immunol 82(3 Pt 1), 470–480 (1988).
   Google Scholar
• Levy DA, Lichtenstein LM, Goldstein EO, Ishizaka K Immunologic and cellular changes accompanying the therapy of pollen allergy.' Clin. Invest. 50(2), 360–369 (1971).
   Google Scholar
• Brunet C, Bedard PM, Lavoie A, Jobin M, Hebert J. Allergic rhinitis to ragweed pollen. I. llen I Reassessment of the effects of immunotherapy on cellular and humoral responses.j Allergy Clin. Immunol 89(1 Pt 1), 76–86 (1992).
   Google Scholar
• Pierkes M, Bellinghausen I, Hultsch T, Metz G, Knop J, Saloga J. Decreased release of histamine and sulfidoleukotrienes by human peripheral blood leukocytes after wasp venom immunotherapy is partially due to induction of IL-10 and IFN-gamma production of T-cells. J. Allergy Clin. Immunol 103(2 Part 1), 326–332 (1999).
   Google Scholar
• Otsuka H, Mezawa A, Ohnishi M, Okubo K, Seki H, Okuda M. Changes in nasal metachromatic cells during allergen immunotherapy. Clin. Exp. Allergy21(1), 115–119 (1991).
   Google Scholar
• Durham SR, Varney VA, Gaga M et al Grass pollen immunotherapy decreases the number of mast cells in the skin. Clin. Exp. Allergy29(11), 1490–1496 (1999).
   Google Scholar
• Klimek L, Wolf H, Mewes T, Dormann D et al The effect of short—term immunotherapy with molecular standardized grass and rye allergens on eosinophil cationic protein and tryptase in nasal secretions. J. Allergy Clin. Immunol 103(1 Pt 1), 47–53 (1999).
   Google Scholar
• Moller C, Dreborg S, Einarsson R. Immunotherapy to deciduous tree pollens: specific IgE and IgG antibody patterns. Clin. Allergy17(6), 551–562 (1987).
   Google Scholar
• Moverare R, Sorva R, Metso T, Vesterinen E, Elfman L, Haahtela T Pollen-specific rush immunotherapy: clinical efficacy and effects on antibody concentrations. Ann. Allergy Asthma Immunol 86(3), 337–342 (2001).
   PubMedGoogle Scholar
• Moverare R, Rak S, Elfman L. Allergen- specific increase in interleukin 010–4 and IL-5 secretion from peripheral blood mononuclear cells during birth-pollen immunotherapy. Allergy53(3), 275–281 (1998).
   Google Scholar
• Benjaponpitak S, Oro A, Maguire P, Marinkovich V, DeKruyff PH, Umetsu DT The kinetics of change in cytokine production by CD4 T-cells during conventional allergen immunotherapy. J. Allergy Gun. Immunol 103(3 Pt 1), 468–475 (1999).
   Google Scholar
• Secrist H, DeKruyff RH, Umetsu DT Interleukin-4 production by CD4+ T-cells from allergic individuals is modulated by antigen concentration and antigen-presenting cell type. J. Exp. Med. 181 (3), 1081–1089 (1995).
   Google Scholar
• Constant S, Pfeiffer C, Woodard A, Pasqualini T, Bottomly K. Extent of T-cell receptor ligation can determine the functional differentiation of naive CD4+ T-cells. J. Exp. Med 182(5), 1591–1596 (1995).
   Google Scholar
• Mailing HJ, Skov PS, Permin H, Nom S, Weeke B. Basophil histamine release and humoral changes during immunotherapy. Dissociation between basophil-bound specific IgE, serum value and cell sensitivity. Allergy37(3), 187–190 (1982).
   Google Scholar
• Hakansson L, Heinrich C, Rak S, Venge P. Activation of B-lymphocytes during pollen season. Effect of immunotherapy. Clin. Exp. Allergy 28 (7), 791–798 (1998).
   Google Scholar
• Lundgren M, Persson U, Larsson P et al Interleukin-4 induces synthesis of IgE and IgG4 in human B-cells. Eur.j Immunol 19(7), 1311–1315 (1989).
   Google Scholar
• Jeannin P, Lecoanet S, Delneste Y, Gauchat JF, Bonnefoy JY. IgE versus IgG4 production can be differentially regulated by IL-10. J. Immunol 160(7), 3555–3561 (1998).
   Google Scholar
• Vrtala S, Ball T, Spitzauer S, Pandjaitan B etal. Immunization with purified natural and recombinant allergens induces mouse IgG1 antibodies that recognize similar epitopes as human IgE and inhibit the human IgE-allergen interaction and allergen-induced basophil degranulation. Immunol 160(12), 6137–6144 (1998).
   Google Scholar
• van Neerven RJ, Wikborg T, Lund G et al. Blocking antibodies induced by specific allergy vaccination prevent the activation of CD4(+) T-cells by inhibiting serum-IgE-facilitated allergen presentation. J. Immunol 163(5), 2944–2952 (1999).
   Google Scholar
• Baskar S, Hamilton RG, Norman PS, Ansari AA. Grass immunotherapy induces inhibition of allergen-specific human peripheral blood mononuclear cell proliferation. Int. Arch. Allergy Immunol 112(2), 184-190(1997).
   Google Scholar
• Moverare R, Elfman L, Bjomsson E, Stalenheim G. Cytokine production by peripheral blood mononuclear cells following birch-pollen immunotherapy. Immunol Lett. 73,51–56 (2000).
   PubMed Web of Science ®Google Scholar
• Ebner C, Siemann U, Bohle et al. Immunological changes during specific immunotherapy of grass pollen allergy: reduced lymphoproliferative responses to allergen and shift from Th2 to Thl in T-cell clones specific for PM p 1, a major grass pollen allergen. Clin. Exp. Allergy 27(9), 1007–1015 (1997).
   Google Scholar
• •Indicates that Th cell tolerance and immune deviation from Th2—Thl-type responses are significant mechanisms of pollen SIT.
   Google Scholar
• Evans R, Pence H, Kaplan H, Rocklin RE. The effect of immunotherapy on humoral and cellular responses in ragweed hayfever. Clin. Invest. 57(5), 1378–1385 (1976).
   Google Scholar
• Lack G, Nelson HS, Amran D etal. Rush immunotherapy results in allergen-specific alterations in lymphocyte function and interferon-gamma production in CD4+ T-cells. J. Allergy an. Immunol 99(4), 530–538 (1997).
   Google Scholar
• Till S, Walker S, Dickason R et al. IL-5 production by allergen-stimulated T-cells following grass pollen immunotherapy for seasonal allergic rhinitis. Clin. Exp. Immunol 110(1), 114–121 (1997).
   Google Scholar
• Klimek L, Dormann D, Jarman ER, Cromwell 0, Riechelmann H, Reske-Kunz AB. Short-term preseasonal birch pollen allergoid immunotherapy influences symptoms, specific nasal provocation and cytokine levels in nasal secretions but not peripheral T-cell responses, in patients with allergic rhinitis. Clin. Exp. Allergy29, 1326–1335 (1999).
   Google Scholar
• Akdis CA, Blesken T, Akdis M, Wuthrich B, Blaser K. Role of interleukin-10 in specific immunotherapy. j Clin. Invest. 102(1), 98–106 (1998).
   Google Scholar
• Platts-Mills T, Vaughan J, Squillace S, Woodfolk J, Sporik R. Sensitisation, asthma and a modified Th2 response in children exposed to cat allergen: a population-based cross-sectional study. Lancet 357(9258), 752–756 (2001).
   Google Scholar
• Leonard C, Tormey V, Burke C, Poulter LW Allergen-induced cytokine production in atopic disease and its relationship to disease severity. Am. J. Respir. Cell Md. Biol. 17(3), 368–375 (1997).
   Google Scholar
• Wurtzen PA, Wissenbach M, Ipsen H, Bufe A, Arnved J, van Neerven RJJ. Highly heterogeneous Phi p 5-specific T-cells from patients with allergic rhinitis differentially recognize recombinant Phi p5 isoallergens. Allergy Clin. Immunol 104 (1), 115–122 (1999).
   Google Scholar
• van Neerven RJ, van de Pol MM, van Milligen FJ et al Characterization of cat dander-specific T-lymphocytes from atopic patients. J. Immund 152 (8), 4203–4210 (1994).
   PubMedGoogle Scholar
• Secrist H, Chelen CJ, Wen Y, Marshall JD, Umetsu DT Allergen immunotherapy decreases interleukin-4 production in CD4+ T-cells from allergic individuals. J. Exp. Med. 178(6), 2123–2130 (1993).
   Google Scholar
• Wachholz PA, Noun-Aria KT, Wilson DR et al Grass pollen immunotherapy for hayfever is associated with increases in local nasal but not peripheral Th1:Th2 cytokine ratios. Immunology105 (1), 56–62 (2002).
   Google Scholar
• •Indicates an immune deviation from a Th2—Th1-type response in nasal mucosa but not in peripheral T-cells after pollen SIT.
   Google Scholar
• Varney VA, Hamid QA, Gaga M et al. Influence of grass pollen immunotherapy on cellular infiltration and cytokine mRNA expression during allergen-induced late-phase cutaneous responses. J. Clin. Invest. 92,644–651 (1993).
   PubMed Web of Science ®Google Scholar
• Hamid QA, Schotman E, Jacobson MR, Walker SM, Durham SR Increases in IL-12 messenger RNA+ cells accompany inhibition of allergen-induced late skin responses after successful grass pollen immunotherapy. J. Allergy Clin. Immunol 99(2), 254–260 (1997).
   Google Scholar
• •Demonstrates an increased IL-12 mRNA expression by APCs after pollen SIT which might be an important mechanism of SIT.
   Google Scholar
• Cottrez F, Hurst SD, Coffman RL, Groux H. T regulatory cells 1 inhibit a Th2-specific response in viva J. Immunol 165(9), 4848–4853 (2000).
   Google Scholar
• Valenta R, Lidholm J, Niederberger V, Hayek B, Kraft D, Gronlund H. The recombinant allergen-based concept of component-resolved diagnostics and immunotherapy (CRD and CRIT). Exp. Allergy 29 (7), 896–904 (1999).
   Google Scholar
• •Explains the concept of component-resolved diagnostics and iminunotherapy.
   Google Scholar
• Ahlstedt S. Understanding the usefulness of specific IgE blood tests in allergy. Clin. Exp. Allergy 32(1), 11–16 (2002).
   Google Scholar
• Moverare R, Elfman L, Vesterinen E, Metso T, Haahtela T Development of new IgE specificities to allergenic components in birch pollen extract during specific immunotherapy studied with immunoblotting and Pharmacia CAP System. Allergy57 (5), 423–430 (2002).
   PubMedGoogle Scholar
• Richter M, Sehon AH, Gordon J, Gregoire C, Rose B. Demonstration of reagin of a new specificity in sera of treated ragweed-sensitive persons. J. Allergy29,287–292 (1958).
   Google Scholar
• Birkner T, Rumpold H, Jarolim E et al Evaluation of immunotherapy-induced changes in specific IgE, IgG and IgG subclasses in birch pollen allergic patients by means of immunoblotting. Correlation with clinical response. Allergy 45(6), 418–426 (1990).
   PubMedGoogle Scholar
• van Ree R, Antonicelli L, Akkerdaas JH, Garritani MS, Aalberse RC, Bonifazi Possible induction of food allergy during mite immunotherapy. Allergy51 (2), 108–113 (1996).
   PubMedGoogle Scholar
• Pajno GB, La Grutta S, Barberio G, Canonica GW, Passalacqua G. Harmful effect of immunotherapy in children with combined snail and mite allergy. J. Allergy Immunol 109(4), 627–629 (2002).
   PubMed Web of Science ®Google Scholar
• Norman PS, Winkenwerder WL, Lichtenstein LM. Immunotherapy of hay fever with ragweed antigen E: comparisons with whole pollen extract and placebos. J. Allergy 42(2), 93–108 (1968).
   Google Scholar
• van Neerven RJ, Arnved J, Ipsen H. Phleum pratense-specific T-cells of allergic rhinitis patients display a broader recognition pattern than phleum pratense-specific serum immunoglobulin E. Clin. Exp. Allergy 30(2), 242–254 (2000).
   Google Scholar
• Valenta R, Sperr WR, Ferreira F etal. Induction of specific histamine release from basophils with purified natural and recombinant birch pollen allergens. J. Allergy Clin. Immunol 91(1 Pt 1), 88-97(1993).
   Google Scholar
• Ferreira F, Hirtenlehner K, Jilek A et al. Dissection of immunoglobulin E and T-lymphocyte reactivity of isoforms of the major birch pollen allergen Bet v 1: potential use of hypoallergenic isoforms for immunotherapy. J. Exp. Med 183(2), 599–609 (1996).
   Google Scholar
• Sparholt SH, Larsen JN, Ipsen H, Schou C, van Neerven RJ. Crossreactivity and T-cell epitope specificity of Bet v 1- specific T-cells suggest the involvement of multiple isoallergens in sensitization to birch pollen. Clin. Exp. Allergy 27(8), 932–941 (1997).
   Google Scholar
• Swoboda I, De Weerd N, Bhalla PL et al. Mutants of the major ryegrass pollen allergen, Lol p 5, with reduced IgE-binding capacity: candidates for grass pollen-specific immunotherapy. Eur j Immunol 32 (1), 270–280 (2002).
   Google Scholar
• van Hage-Hamsten M, Johansson E, Roquet A et al. Nasal challenges with recombinant derivatives of the major birch pollen allergen Bet v 1 induce fewer symptoms and lower mediator release than rBet v 1 wild type in patients with allergic rhinitis. Clin. Exp. Allergy32(10), 1448–1453 (2002).
   Google Scholar
• Linhart B, Jahn-Schmid B, Verclino P et al. Combination vaccines for the treatment of grass pollen allergy consisting of genetically engineered hybrid molecules with increased immunogenicity. FASEB 16 (10), 1301–1303 (2002).
   PubMedGoogle Scholar
• Haselden BM, Kay AB, Larche M. Peptide-mediated immune responses in specific immunotherapy. Int. Arch. Allergy Immunol 122(4), 229–237 (2000).
   Google Scholar
• Basomba A, Tabar Al, de Rojas DH et al. Allergen vaccination with a liposome-encapsulated extract of Dermatophagoides pteronyssinus: a randomized, double-blind, placebo-controlled trial in asthmatic patients. J. Allergy Clin. Immunol 109 (6), 943–948 (2002).
   Google Scholar
• Wheeler AW, Marshall JS, Ulrich JT. A Thl -inducing adjuvant, MPL, enhances antibody profiles in experimental animals suggesting it has the potential to improve the efficacy of allergy vaccines. Lit. Arch. Allergy Immunol 126(2), 135–139 (2001).
   Google Scholar
• Santeliz JV, Van Nest G, Traquina P, Larsen E, Wills-Karp M. Amb a 1-linked CpG oligodeoxynudeotides reverse established airway hyperresponsiveness in a murine model of asthma. J. Allergy Clin. Immunol 109(3), 455–462 (2002).
   Google Scholar
• Gronlund H, Vrtala S, Wiedermann U et al Carbohydrate-based particles: a new adjuvant for allergen-specific immunotherapy. Immunology107(4), 523–529 (2002).
   PubMedGoogle Scholar
• Hamelmann E, Rolinck-Werninghaus C, Wahn U. From IgE to anti-IgE: where do we stand? Allergy57 (11), 983–994 (2002).
   Google Scholar